SuRf-project - stress reduction and promotion of resilience in children and adolesents with type 1 diabetes

SuRf-project - stress reduction and promotion of resilience in children and adolesents with type 1 diabetes - SuRf

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00020759

Enrollment

Registered

2020-02-07

Start date

2019-04-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E10

Interventions

Group 1: Telemedicine Group 2: Telemedicine and mindfulness-based training Group 3: Telemedicine and physical training Group 4: Control group

Eligibility

Sex/Gender

All

Age

12 Years to 18 Years

Inclusion criteria

Inclusion criteria: • Patients aged 12 to 18 years suffering from Diabetes mellitus type 1 • Intensified conventional therapy (ICT) or continuous subcutaneous insulin infusion (CSII) • Diabetes training by the team of “Kinderkrankenhaus Amsterdamer Straße” • Flash glucose monitoring (FGM) or continuous glucose monitoring (CGM) • Sufficient knowledge of the German language • Normal intelligence • Compliant • Signed informed consent

Exclusion criteria

Exclusion criteria: • Diabetes < 6 months • Learning disability • Competitive sports or more than 60 min of physical exercise per day • Psychiatric comorbidity. Medically treated ADHS patients can participate • Lack of informed consent

Design outcomes

Primary

Measure	Time frame
Time in range (%) The time in range, i.e. the percentage time of the blood glucose value in the target range 70 and 180mg/dl, represents the primary outcome . The "continuous glucose monitoring" or "flash glucose monitoring" provide the possibility of graphic processing of the blood glucose values. At baseline, after three, six and twelve months a period of two weeks is considered. A prerequisite is that the sensor must have been worn at least 70-80% of the time during this period.	—

Measure

Time frame

Time in range (%) The time in range, i.e. the percentage time of the blood glucose value in the target range 70 and 180mg/dl, represents the primary outcome . The "continuous glucose monitoring" or "flash glucose monitoring" provide the possibility of graphic processing of the blood glucose values. At baseline, after three, six and twelve months a period of two weeks is considered. A prerequisite is that the sensor must have been worn at least 70-80% of the time during this period.

—

Secondary

Measure	Time frame
Quality of life and fitness are defined as secondary outcomes. The quality of life of the patients and their parents is determined by means of standardized questionnaires at baseline, as well as after three, six and twelve months. The patients´ fitness is assessed at baseline, as well as after three, six and twelve months using a shuttle-run test.	—

Countries

Germany

Contacts

Public ContactKirsten Mönkemöller

Kinderkrankenhaus Amsterdamer StraßeKliniken der Stadt Köln gGmbH

MoenkemoellerK@kliniken-koeln.de0049 221-8907 15053

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026